HK1033753A1 - Benzamide derivatives for the treatment of diseases mediated by cytokines. - Google Patents

Benzamide derivatives for the treatment of diseases mediated by cytokines.

Info

Publication number
HK1033753A1
HK1033753A1 HK01104299A HK01104299A HK1033753A1 HK 1033753 A1 HK1033753 A1 HK 1033753A1 HK 01104299 A HK01104299 A HK 01104299A HK 01104299 A HK01104299 A HK 01104299A HK 1033753 A1 HK1033753 A1 HK 1033753A1
Authority
HK
Hong Kong
Prior art keywords
cytokines
treatment
diseases mediated
benzamide derivatives
6alkoxy
Prior art date
Application number
HK01104299A
Other languages
English (en)
Inventor
Dearg Sutherland Brown
George Robert Brown
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810356.7A external-priority patent/GB9810356D0/en
Priority claimed from GBGB9905970.1A external-priority patent/GB9905970D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1033753A1 publication Critical patent/HK1033753A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK01104299A 1998-05-15 2001-06-20 Benzamide derivatives for the treatment of diseases mediated by cytokines. HK1033753A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9810356.7A GB9810356D0 (en) 1998-05-15 1998-05-15 Amide derivatives
GBGB9905970.1A GB9905970D0 (en) 1999-03-17 1999-03-17 Amide derivatives
PCT/GB1999/001491 WO1999059960A1 (en) 1998-05-15 1999-05-11 Benzamide derivatives for the treatment of diseases mediated by cytokines

Publications (1)

Publication Number Publication Date
HK1033753A1 true HK1033753A1 (en) 2001-09-21

Family

ID=26313677

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104299A HK1033753A1 (en) 1998-05-15 2001-06-20 Benzamide derivatives for the treatment of diseases mediated by cytokines.

Country Status (23)

Country Link
US (1) US6465455B1 (xx)
EP (1) EP1077930B1 (xx)
JP (1) JP2003505337A (xx)
KR (1) KR100628284B1 (xx)
CN (1) CN1188389C (xx)
AT (1) ATE282023T1 (xx)
AU (1) AU748397B2 (xx)
BR (1) BR9910467A (xx)
CA (1) CA2328699A1 (xx)
DE (1) DE69921804T2 (xx)
ES (1) ES2230853T3 (xx)
HK (1) HK1033753A1 (xx)
HU (1) HUP0102367A3 (xx)
ID (1) ID27285A (xx)
IL (1) IL139710A (xx)
NO (1) NO20005766L (xx)
NZ (1) NZ507143A (xx)
PL (1) PL197181B1 (xx)
PT (1) PT1077930E (xx)
RU (1) RU2205823C2 (xx)
SK (1) SK286247B6 (xx)
TR (1) TR200003355T2 (xx)
WO (1) WO1999059960A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772432B2 (en) 1991-09-19 2010-08-10 Astrazeneca Ab Amidobenzamide derivatives which are useful as cytokine inhibitors
GB9816837D0 (en) 1998-08-04 1998-09-30 Zeneca Ltd Amide derivatives
IL134723A0 (en) 1997-09-23 2001-04-30 Zeneca Ltd Amide derivatives for the treatment of diseases mediated by cytokines
NZ507144A (en) 1998-05-15 2002-10-25 Astrazeneca Ab Benzamide derivatives useful for the treatment of diseases mediated by cytokines
PL197181B1 (pl) 1998-05-15 2008-03-31 Astrazeneca Ab Pochodna benzamidowa, sposób jej wytwarzania, jej kompozycja farmaceutyczna i jej zastosowanie do wytwarzania leku
EP1102750A1 (en) 1998-08-04 2001-05-30 AstraZeneca AB Amide derivatives useful as inhibitors of the production of cytokines
WO2000010563A1 (en) 1998-08-20 2000-03-02 Smithkline Beecham Corporation Novel substituted triazole compounds
RU2219171C2 (ru) 1998-09-25 2003-12-20 Астразенека Аб Производные амида, способ их получения и фармацевтическая композиция на их основе
IL145357A0 (en) 1999-03-17 2002-06-30 Astrazeneca Ab Amide derivatives
WO2000055120A1 (en) * 1999-03-17 2000-09-21 Astrazeneca Ab Amide derivatives
GB9906566D0 (en) 1999-03-23 1999-05-19 Zeneca Ltd Chemical compounds
GB9924092D0 (en) 1999-10-13 1999-12-15 Zeneca Ltd Pyrimidine derivatives
AU1781601A (en) 1999-11-23 2001-06-04 Smithkline Beecham Corporation 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
US6943161B2 (en) 1999-12-28 2005-09-13 Pharmacopela Drug Discovery, Inc. Pyrimidine and triazine kinase inhibitors
WO2002049632A1 (fr) * 2000-12-18 2002-06-27 Institute Of Medicinal Molecular Design. Inc. Inhibiteurs de production et de liberation de cytokines inflammatoires
CA2439410C (en) 2001-02-27 2011-09-06 William D. Figg Analogs of thalidomide as potential angiogenesis inhibitors
AU2003242098B2 (en) * 2002-06-10 2008-11-20 Institute Of Medicinal Molecular Design, Inc Inhibitors against activation of NFkappaB
AU2003281198A1 (en) * 2002-07-04 2004-01-23 Mitsui Chemicals, Inc. m-PHENYLENEDIAMINE DERIVATIVE
WO2004004725A2 (en) 2002-07-09 2004-01-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
WO2005028436A2 (en) 2003-09-17 2005-03-31 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
GB0324790D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1953148B1 (en) 2005-10-28 2012-02-29 Takeda Pharmaceutical Company Limited Heterocyclic amide compound and use thereof
JP5225857B2 (ja) * 2005-11-14 2013-07-03 ジェネンテック，インコーポレイティド ヘッジホッグシグナル伝達のビスアミド阻害剤
WO2007120669A1 (en) 2006-04-13 2007-10-25 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Tetrahalogenated compounds useful as inhibitors of angiogenesis
US7671058B2 (en) * 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives
WO2008089034A2 (en) * 2007-01-11 2008-07-24 Kemia, Inc. Cytokine inhibitors
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
CN104326937B (zh) * 2014-09-03 2016-08-24 天津市肿瘤研究所 抗肿瘤化合物及其医药用途
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1903899A (en) 1933-04-18 Cabboxylic acid abylides oe the benzene sebies and process oe making
US1909960A (en) 1929-08-06 1933-05-23 Du Pont Intermediate for azo dyes
DE2812252A1 (de) 1978-03-21 1979-10-04 Bayer Ag 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel
US4524168A (en) 1981-11-18 1985-06-18 Ciba-Geigy Corporation Process for the mass coloration of polymers
US4749729A (en) 1984-06-21 1988-06-07 American Cyanamid Company Epoxy resin compositions curable above 160 F. and below 250 F.
AU2552492A (en) 1991-08-23 1993-03-16 United States of America as represented by The Secretary Department of Health and Human Services, The Raf protein kinase therapeutics
GB9816837D0 (en) 1998-08-04 1998-09-30 Zeneca Ltd Amide derivatives
EP0871444A4 (en) 1995-08-10 1999-01-13 Merck & Co Inc 2.5 SUBSTITUTED ARYL PYRROL, THE COMPOSITIONS THAT CONTAIN AND THE USE THEREOF
US6174887B1 (en) * 1995-08-22 2001-01-16 Japan Tobacco Inc. Amide compounds and use of the same
GB9604926D0 (en) 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
EP0922042A1 (en) 1996-08-09 1999-06-16 Smithkline Beecham Corporation Novel piperazine containing compounds
GB9623833D0 (en) 1996-11-16 1997-01-08 Zeneca Ltd Chemical compound
IL134723A0 (en) * 1997-09-23 2001-04-30 Zeneca Ltd Amide derivatives for the treatment of diseases mediated by cytokines
GB9809347D0 (en) 1998-05-05 1998-07-01 Reckitt & Colmann Prod Ltd Compositions
PL197181B1 (pl) 1998-05-15 2008-03-31 Astrazeneca Ab Pochodna benzamidowa, sposób jej wytwarzania, jej kompozycja farmaceutyczna i jej zastosowanie do wytwarzania leku
NZ507144A (en) 1998-05-15 2002-10-25 Astrazeneca Ab Benzamide derivatives useful for the treatment of diseases mediated by cytokines
EP1102750A1 (en) 1998-08-04 2001-05-30 AstraZeneca AB Amide derivatives useful as inhibitors of the production of cytokines
RU2219171C2 (ru) 1998-09-25 2003-12-20 Астразенека Аб Производные амида, способ их получения и фармацевтическая композиция на их основе
US6593333B1 (en) 1998-10-01 2003-07-15 Astrazeneca Ab Substituted anilino-quinazoline (or quinoline) compounds and use thereof
WO2000055120A1 (en) 1999-03-17 2000-09-21 Astrazeneca Ab Amide derivatives
IL145357A0 (en) 1999-03-17 2002-06-30 Astrazeneca Ab Amide derivatives
GB9924092D0 (en) 1999-10-13 1999-12-15 Zeneca Ltd Pyrimidine derivatives

Also Published As

Publication number Publication date
CA2328699A1 (en) 1999-11-25
DE69921804T2 (de) 2005-10-27
ID27285A (id) 2001-03-22
EP1077930B1 (en) 2004-11-10
PL197181B1 (pl) 2008-03-31
KR100628284B1 (ko) 2006-09-27
CN1359371A (zh) 2002-07-17
ES2230853T3 (es) 2005-05-01
PT1077930E (pt) 2005-03-31
EP1077930A1 (en) 2001-02-28
CN1188389C (zh) 2005-02-09
AU3839299A (en) 1999-12-06
JP2003505337A (ja) 2003-02-12
DE69921804D1 (de) 2004-12-16
NO20005766D0 (no) 2000-11-14
HUP0102367A3 (en) 2002-11-28
WO1999059960A1 (en) 1999-11-25
IL139710A0 (en) 2002-02-10
PL344185A1 (en) 2001-10-08
KR20010043547A (ko) 2001-05-25
HUP0102367A2 (hu) 2001-10-28
SK17172000A3 (sk) 2001-04-09
NO20005766L (no) 2001-01-12
TR200003355T2 (tr) 2001-03-21
IL139710A (en) 2005-07-25
ATE282023T1 (de) 2004-11-15
BR9910467A (pt) 2001-01-09
AU748397B2 (en) 2002-06-06
SK286247B6 (sk) 2008-06-06
NZ507143A (en) 2003-08-29
US6465455B1 (en) 2002-10-15
RU2205823C2 (ru) 2003-06-10

Similar Documents

Publication Publication Date Title
IL139710A (en) Benzamide derivatives for the treatment of diseases mediated by cytokines
DE69810134D1 (de) Amide derivativen zur behandlung von durch cytokinen vermittelten krankheiten
NZ509318A (en) Amide derivatives, their preparation and use in the treatment of diseases mediated by cytokines
GB8823731D0 (en) Biologically active compounds
ATE136027T1 (de) Therapeutische amide
MY142177A (en) Benzamide derivatives useful as histone deacetylase inhibitors
HUT46708A (en) Process for producing heterocyclic ketones and pharmaceutical compositions containing them as active components
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
DE69531502D1 (de) Monoamid, diamid, thiol enthaltende metall-chelatierende verbindungen
AP9701041A0 (en) Pyridylpyrrole compounds.
GB9305295D0 (en) Therapeutic compounds
IL111036A0 (en) Beta_alanine derivatives, processes for the preparon thereof and pharmaceutical compositions containing the same
GB9310095D0 (en) Therapeutic compounds
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
IL107315A0 (en) 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them
ES2095186A1 (es) Derivados de epi-epibatidina.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DK585986D0 (da) Forbindelser beslaegtet med antibiotikum tan-749 og fremgangsmaade til fremstilling deraf
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
HUT47900A (en) Process for producing new amides of butenic acid and pharmaceutical compositions containing them as active components

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090511